Peptide-mediated Pausing of Translation

肽介导的翻译暂停

• 批准号: 0920578
• 负责人: Lasse Lindahl
• 金额: $ 60.99万
• 依托单位: University of Maryland Baltimore County
• 依托单位国家: 美国
• 项目类别: Continuing Grant
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0920578&HistoricalAwards=false
• 关键词: Peptide; mediated; Pausing; Translation

The ribosome is the organelle that translates the genetic code into proteins in all types of living cells. The ribosome has two subunits, a small subunit that is responsible for decoding the genetic information, and a large subunit where coupling of amino acids into a protein takes place. Newly synthesized proteins exit the ribosome through a long, narrow tunnel in the large ribosomal subunit. Under some circumstances, growth of specific proteins is interrupted for short or long periods of time. This project addresses the mechanisms that control which proteins are subject to such arrest of synthesis. Current evidence indicates that the stoppage involves interactions between the portion of the protein that was synthesized immediately before the polymerization arrest and RNA and/or protein components of the tunnel. The project focuses on a very short protein (CrbCmlA; only 9 amino acids long), which is involved in the regulation of another protein (CmlA) that makes cells resistant to the ribosome-targeting antibiotic chloramphenicol. A low concentration of chloramphenicol (insufficient to inhibit ribosomes synthesizing other proteins) is required to arrest the polymerization of CrbCmlA, but it is not known how or why chloramphenicol specifically inhibits synthesis of this protein. The hypothesis is that the growing protein and chloramphenicol both interact with ribosomal RNA and proteins to bring about the conditions that stop synthesis. The experiments in this project are designed to define which features of each of the three interacting components (CrbCmlA, the ribosome and chloramphenicol) are required for this tri-component interaction and how these interactions establish translation arrest. The bacterium Escherichia coli is chosen as the experimental organism because of the ease of its genetic manipulation and the availability of procedures for biochemical analysis of its ribosomes. Specifically, the study will employ a mixture of genetic, biochemical, and physiological methods to (1) identify critical features of the CrbCmlA pausing peptide (length, sequence, and electrostatic properties), the ribosome, and the co-inducer necessary for pausing, (2) characterize the interactions between CrbCmlA, ribosomal components, and chloramphenicol, and (3) probe the effect(s) of CrbCmlA on the interaction of chloramphenicol with the ribosome. For context, pausing of Crb will be compared with translational arrest of another protein (SecM), which does not require binding of a separate molecule to the ribosome. The collective results of these experiments will provide model(s) for the molecular mechanism of translation arrest and comparison of the results for experiments with the two proteins will reveal whether peptide synthesis pausing can be explained by a single mechanism or if there are different pausing pathways in the ribosome.This research will have impact in two areas. First, it will generate a more comprehensive understanding of the function of the ribosome, an organelle that is universally required for the survival and growth of all types of biological cells. Second, it will provide training opportunities for both graduate and undergraduate students in biological research that integrate molecular genetics with advanced biochemical probing of interactions in a major multi-component complex.

核糖体是在所有类型的活细胞中将遗传密码翻译成蛋白质的细胞器。核糖体有两个亚基，一个负责解码遗传信息的小亚基，和一个发生氨基酸偶联成蛋白质的大亚基。新合成的蛋白质通过核糖体大亚基中的狭长通道离开核糖体。在某些情况下，特定蛋白质的生长会中断一段或长或短的时间。这个项目解决了控制哪些蛋白质受到这种合成停滞的机制。目前的证据表明，停止涉及的蛋白质的一部分，在聚合停滞和RNA和/或蛋白质组分的隧道之前立即合成之间的相互作用。该项目的重点是一种非常短的蛋白质（CrbCmlA;只有9个氨基酸长），它参与调节另一种蛋白质（CmlA），使细胞对核糖体靶向抗生素氯霉素产生抗性。需要低浓度的氯霉素（不足以抑制核糖体合成其他蛋白质）来阻止CrbCmlA的聚合，但尚不清楚氯霉素如何或为什么特异性抑制这种蛋白质的合成。假设是生长的蛋白质和氯霉素都与核糖体RNA和蛋白质相互作用，导致合成停止。该项目中的实验旨在定义三种相互作用组分（CrbCmlA，核糖体和氯霉素）中的每一种的哪些特征是这种三组分相互作用所需的，以及这些相互作用如何建立翻译停滞。选择大肠杆菌作为实验生物体是因为它易于遗传操作，并且可以对其核糖体进行生化分析。具体而言，该研究将采用遗传学、生物化学和生理学方法的混合物来（1）鉴定CrbCmlA暂停肽的关键特征（长度、序列和静电性质）、核糖体和暂停所必需的共诱导物，（2）表征CrbCmlA、核糖体组分和氯霉素之间的相互作用，（3）探讨CrbCmlA对氯霉素与核糖体相互作用的影响。对于上下文，Crb的暂停将与另一种蛋白质（SecM）的翻译停滞进行比较，后者不需要单独的分子与核糖体结合。这些实验的综合结果将为翻译停滞的分子机制提供模型，而两种蛋白质实验结果的比较将揭示肽合成暂停是否可以由单一机制解释，或者是否在核糖体中存在不同的暂停途径。首先，它将产生对核糖体功能的更全面的理解，核糖体是所有类型生物细胞生存和生长所普遍需要的细胞器。第二，它将为生物学研究的研究生和本科生提供培训机会，将分子遗传学与主要多组分复合物中相互作用的高级生物化学探测相结合。